Eliem Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | n/a |
Management average tenure | 1.2yrs |
Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation
Feb 01We Think Eliem Therapeutics (NASDAQ:ELYM) Needs To Drive Business Growth Carefully
Jun 24We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate
Mar 08We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate
Nov 18Eliem Therapeutics GAAP EPS of -$0.56 misses by $0.09
Aug 15Eliem to discontinue development of lead asset as mid-stage pain trial fails
Aug 02SVB Leerink cuts PT on Eliem Therapeutics, reaffirms Outperform rating
Jul 11CEO
Eliem Therapeutics has no CEO, or we have no data on them.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Principal Financial Officer & Executive Chairman | 5.2yrs | US$96.34k | no data | |
Chief Scientific Officer and Executive VP of Research & Development | 5yrs | US$1.99m | 1.8% $ 2.0m | |
Principal Accounting Officer | 1.2yrs | no data | no data | |
Chief Development Officer | no data | no data | no data |
1.2yrs
Average Tenure
45yo
Average Age
Experienced Management: ELYM's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Principal Financial Officer & Executive Chairman | 5.2yrs | US$96.34k | no data | |
Independent Director | 3.5yrs | US$70.84k | 0.64% $ 689.2k | |
Lead Independent Director | 4.5yrs | US$68.34k | 0% $ 0 | |
Independent Director | 5.2yrs | US$23.34k | 0% $ 0 | |
Independent Director | 3.2yrs | US$63.34k | 0% $ 0 |
4.5yrs
Average Tenure
56yo
Average Age
Experienced Board: ELYM's board of directors are considered experienced (4.5 years average tenure).